Podcast
Livingdiabetes
Hosted by FWA · EN
The "LivingDiabetes Podcast" is a dedicated audio platform for anyone looking to deepen their understanding of health-related issues, focusing mainly on diabetes and endocrinology. The podcast is focused on empowering listeners with knowledge and practical advice for managing life with diabetes. Join us as we explore health-related issues, including diabetes, with the goal of enhancing the health outcomes and quality of life for those who suffer from this chronic condition.
27episodes
Episodes
Newest firstAll episodes
HIIT vs Steady-State Cardio: Which Is Better for Blood Sugar Control?
2w ago00:04:47Tap to summarizeIn this episode, we compare high-intensity interval training and steady-state cardio for diabetes management. We break down how each type affects blood sugar differently, review meta-analysis data showing HIIT may produce slightly greater A1C reductions in less time, explain why blood sugar can rise during HIIT sessions, discuss safety considerations for insulin users and those with complications, and recommend the optimal combined approach. Follow us on social media for updates and more content.
Transcribe →Diabetic Retinopathy: Protecting Your Vision Before Symptoms Appear
3w ago00:04:58Tap to summarizeIn this episode, we walk through all four stages of diabetic retinopathy from mild non-proliferative changes to sight-threatening proliferative disease. We explain why this leading cause of blindness in working-age adults often has no early symptoms, discuss diabetic macular oedema, cover modern treatments including anti-VEGF injections and laser therapy, and provide four actionable steps to protect your vision starting today. Follow us on social media for updates and more content.
Transcribe →Getting Started with Exercise and Diabetes: A Practical Guide
4w ago00:05:14Tap to summarizeIn this episode, we cover everything you need to know about starting an exercise routine with diabetes. We explain why exercise is the closest thing to a wonder drug, break down the ADA guidelines into achievable steps, discuss how exercise timing affects blood sugar including why post-meal walks are the single best habit to add, cover safety considerations for insulin users, and explain why resistance training is especially valuable for glucose control. Follow us on social media for updates and more content.
Transcribe →Diabetes and Eating Disorders: The Hidden Overlap That Can Be Fatal
Apr 2400:04:52Tap to summarizeIn this episode, we explore the dangerous intersection of diabetes and eating disorders, including the life-threatening condition diabulimia where insulin is deliberately restricted for weight loss. We discuss why people with diabetes are more vulnerable to disordered eating, warning signs that are often missed, binge eating disorder in type 2 diabetes, and why integrated care from specialists who understand both conditions produces the best outcomes. Follow us on social media for updates and more content.
Transcribe →GLP-1 Medications and Mood Changes: What the Evidence Actually Says
Apr 1700:05:16Tap to summarizeIn this episode, we examine whether GLP-1 medications like semaglutide and tirzepatide can affect mood and mental health. We explore the science behind GLP-1 receptors in the brain, review clinical trial and real-world evidence, discuss three mechanisms through which these medications could influence mood including direct CNS effects, psychological adjustment to appetite changes, and blood sugar fluctuations, and provide practical guidance for patients and prescribers. Follow us on social media for updates and more content.
Transcribe →World Health Day: The Global Diabetes Crisis in Numbers
Apr 700:05:06Tap to summarizeIn this special World Health Day episode, we look at the global scale of the diabetes epidemic with over 540 million adults affected worldwide. We examine geographic disparities, the insulin access crisis in low-income countries, the staggering economic burden exceeding 960 billion dollars, evidence-based prevention strategies, and the bright spots including national programmes and technology bridging gaps in care. Follow us on social media for updates and more content.
Transcribe →Diabetes Distress vs Clinical Depression: Why Getting It Right Matters
Apr 300:05:06Tap to summarizeIn this episode, we break down the critical difference between diabetes distress and clinical depression, two conditions that look similar but require completely different treatment approaches. We explain what diabetes distress actually is, how it differs from clinical depression, why the distinction matters for treatment decisions, and how validated screening tools like the Diabetes Distress Scale and PHQ-9 can help get the right diagnosis. Follow us on social media for updates and more content.
Transcribe →Stress and Blood Sugar: How Cortisol Quietly Sabotages Your Diabetes Control
Apr 100:05:46Tap to summarizeIn this episode, we explore the science behind how stress hormones, particularly cortisol, directly raise blood sugar through multiple mechanisms including liver glucose release, increased insulin resistance, and chronic inflammation. We explain the hypothalamic-pituitary-adrenal axis, review clinical evidence linking stress to higher A1C values, and provide five practical strategies for managing stress as a core component of diabetes care. Follow us on social media for updates and more content.
Transcribe →Amycretin: The Dual-Action Pill That Could Rival Injections
Mar 2900:05:37Tap to summarizeIn this episode, we explore amycretin, Novo Nordisk's oral dual agonist that targets both GLP-1 and amylin receptors in a single molecule. We break down how it differs from injectable options like CagriSema, review the impressive early trial data showing thirteen percent weight loss in just twelve weeks, discuss why an effective oral option matters for patient access, and look at where it fits in the evolving pipeline of diabetes and obesity medications. Follow us on social media for updates and more content.
Transcribe →Cagri Sema Next Generation Drug Update
Mar 2700:05:30Tap to summarizeIn this episode, we look at CagriSema, a next-generation combination medication that pairs semaglutide with cagrilintide, an amylin analogue. We explain how this dual-pathway approach works, review the impressive phase three clinical trial results showing A1C reductions exceeding two percentage points and weight loss of fifteen to twenty percent, discuss the side effect profile, and explore when this medication might become available. Follow us on social media for updates and more content.
Transcribe →